Cargando…

Applications of MRS in the evaluation of focal malignant brain lesions

Magnetic resonance spectroscopy (MRS) has clinically been most extensively used for assessing brain disorders, particularly tumors. With 1-H spectroscopy at intermediate echo times, resonances from choline, creatine, N-acetyl-aspartate (NAA), lactate, and free fatty acids can be resolved well enough...

Descripción completa

Detalles Bibliográficos
Autores principales: Delorme, S, Weber, M-A
Formato: Texto
Lenguaje:English
Publicado: e-MED 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693767/
https://www.ncbi.nlm.nih.gov/pubmed/16829470
http://dx.doi.org/10.1102/1470-7330.2006.0015
_version_ 1782131201692139520
author Delorme, S
Weber, M-A
author_facet Delorme, S
Weber, M-A
author_sort Delorme, S
collection PubMed
description Magnetic resonance spectroscopy (MRS) has clinically been most extensively used for assessing brain disorders, particularly tumors. With 1-H spectroscopy at intermediate echo times, resonances from choline, creatine, N-acetyl-aspartate (NAA), lactate, and free fatty acids can be resolved well enough to assist in diagnosis under routine conditions. Generally, an increased concentration of choline is found in all primary and secondary brain tumors, and the degree of increase correlates with the degree of anaplasia. Further indicators of anaplasia are the presence of lactate, indicating hypoxia, and of fatty acids, indicating necrosis. According to literature, the sensitivity of a combination of proton spectroscopy with contrast-enhanced dynamic susceptibility-weighted imaging for high-grade components in gliomas is better than conventional contrast-enhanced imaging alone. Today, proton spectroscopy is clearly indicated for differentiating radiation-induced damage from recurrences of irradiated brain tumors.
format Text
id pubmed-1693767
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher e-MED
record_format MEDLINE/PubMed
spelling pubmed-16937672007-06-22 Applications of MRS in the evaluation of focal malignant brain lesions Delorme, S Weber, M-A Cancer Imaging Article Magnetic resonance spectroscopy (MRS) has clinically been most extensively used for assessing brain disorders, particularly tumors. With 1-H spectroscopy at intermediate echo times, resonances from choline, creatine, N-acetyl-aspartate (NAA), lactate, and free fatty acids can be resolved well enough to assist in diagnosis under routine conditions. Generally, an increased concentration of choline is found in all primary and secondary brain tumors, and the degree of increase correlates with the degree of anaplasia. Further indicators of anaplasia are the presence of lactate, indicating hypoxia, and of fatty acids, indicating necrosis. According to literature, the sensitivity of a combination of proton spectroscopy with contrast-enhanced dynamic susceptibility-weighted imaging for high-grade components in gliomas is better than conventional contrast-enhanced imaging alone. Today, proton spectroscopy is clearly indicated for differentiating radiation-induced damage from recurrences of irradiated brain tumors. e-MED 2006-06-22 /pmc/articles/PMC1693767/ /pubmed/16829470 http://dx.doi.org/10.1102/1470-7330.2006.0015 Text en Copyright © 2006 International Cancer Imaging Society
spellingShingle Article
Delorme, S
Weber, M-A
Applications of MRS in the evaluation of focal malignant brain lesions
title Applications of MRS in the evaluation of focal malignant brain lesions
title_full Applications of MRS in the evaluation of focal malignant brain lesions
title_fullStr Applications of MRS in the evaluation of focal malignant brain lesions
title_full_unstemmed Applications of MRS in the evaluation of focal malignant brain lesions
title_short Applications of MRS in the evaluation of focal malignant brain lesions
title_sort applications of mrs in the evaluation of focal malignant brain lesions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693767/
https://www.ncbi.nlm.nih.gov/pubmed/16829470
http://dx.doi.org/10.1102/1470-7330.2006.0015
work_keys_str_mv AT delormes applicationsofmrsintheevaluationoffocalmalignantbrainlesions
AT weberma applicationsofmrsintheevaluationoffocalmalignantbrainlesions